ArticleMultiple sclerosis journal - experimental, translational and clinical
Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis.
Hilde Norborg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.